APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dolutegravir

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dolutegravir Industry Growth and Trends Forecast to 2032

23 December 202592 pages

Choose your research edition.

Industry ResearchDolutegravir Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Dolutegravir Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Dolutegravir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dolutegravir Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Dolutegravir Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Dolutegravir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dolutegravir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dolutegravir is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dolutegravir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dolutegravir include Shanghai Desano Pharmaceuticals, Mylan, ViiV Healthcare (GSK), LAURUS Labs, Aurobindo Pharma and Adcock Ingram Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dolutegravir market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dolutegravir market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dolutegravir market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dolutegravir.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dolutegravir market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dolutegravir Market by Company

Shanghai Desano Pharmaceuticals

Mylan

ViiV Healthcare (GSK)

LAURUS Labs

Aurobindo Pharma

Adcock Ingram Limited

Dolutegravir Segment by Type

10mg Tablets

50mg Tablets

Dolutegravir Segment by Application

Prevent HIV Infection Following Potential Exposure

Others

Dolutegravir Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dolutegravir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dolutegravir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dolutegravir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dolutegravir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dolutegravir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg Tablets Table 2. Major Company of 50mg Tablets Table 3. Global Dolutegravir Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Dolutegravir Sales by Type (2021-2026) & (k pcs) Table 5. Global Dolutegravir Sales Market Share in Volume by Type (2021-2026) Table 6. Global Dolutegravir Sales by Type (2021-2026) & (US$ Million) Table 7. Global Dolutegravir Sales Market Share in Value by Type (2021-2026) Table 8. Global Dolutegravir Price by Type (2021-2026) & (US$/pcs) Table 9. Global Dolutegravir Sales by Type (2027-2032) & (k pcs) Table 10. Global Dolutegravir Sales Market Share in Volume by Type (2027-2032) Table 11. Global Dolutegravir Sales by Type (2027-2032) & (US$ Million) Table 12. Global Dolutegravir Sales Market Share in Value by Type (2027-2032) Table 13. Global Dolutegravir Price by Type (2027-2032) & (US$/pcs) Table 14. North America Dolutegravir Sales by Type (2021-2026) & (k pcs) Table 15. North America Dolutegravir Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Dolutegravir Sales by Type (2021-2026) & (k pcs) Table 17. Europe Dolutegravir Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Dolutegravir Sales by Type (2021-2026) & (k pcs) Table 19. Asia-Pacific Dolutegravir Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Dolutegravir Sales by Type (2021-2026) & (k pcs) Table 21. Latin America Dolutegravir Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Dolutegravir Sales by Type (2021-2026) & (k pcs) Table 23. Middle East and Africa Dolutegravir Sales by Type (2021-2026) & (US$ Million) Table 24. Dolutegravir Industry Trends Table 25. Dolutegravir Industry Drivers Table 26. Dolutegravir Industry Opportunities and Challenges Table 27. Dolutegravir Industry Restraints Table 28. Global Dolutegravir Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Dolutegravir Revenue Market Share by Company (2021-2026) Table 30. Global Dolutegravir Sales by Company (2021-2026) & (k pcs) Table 31. Global Dolutegravir Sales Share by Company (2021-2026) Table 32. Global Dolutegravir Market Price by Company (2021-2026) & (US$/pcs) Table 33. Global Dolutegravir Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dolutegravir Major Company Production Sites and Headquarters Table 35. Global Dolutegravir Company, Product Type & Application Table 36. Global Dolutegravir Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Dolutegravir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dolutegravir Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Dolutegravir Sales by Region (2021-2026) & (k pcs) Table 41. Global Dolutegravir Sales Market Share in Volume by Region (2021-2026) Table 42. Global Dolutegravir Sales by Region (2021-2026) & (US$ Million) Table 43. Global Dolutegravir Sales Market Share in Value by Region (2021-2026) Table 44. Global Dolutegravir Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 45. Global Dolutegravir Sales by Region (2027-2032) & (k pcs) Table 46. Global Dolutegravir Sales Market Share in Volume by Region (2027-2032) Table 47. Global Dolutegravir Sales by Region (2027-2032) & (US$ Million) Table 48. Global Dolutegravir Sales Market Share in Value by Region (2027-2032) Table 49. Global Dolutegravir Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 50. Global Dolutegravir Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Dolutegravir Sales by Application (2021-2026) & (k pcs) Table 52. Global Dolutegravir Sales Market Share in Volume by Application (2021-2026) Table 53. Global Dolutegravir Sales by Application (2021-2026) & (US$ Million) Table 54. Global Dolutegravir Sales Market Share in Value by Application (2021-2026) Table 55. Global Dolutegravir Price by Application (2021-2026) & (US$/pcs) Table 56. Global Dolutegravir Sales by Application (2027-2032) & (k pcs) Table 57. Global Dolutegravir Sales Market Share in Volume by Application (2027-2032) Table 58. Global Dolutegravir Sales by Application (2027-2032) & (US$ Million) Table 59. Global Dolutegravir Sales Market Share in Value by Application (2027-2032) Table 60. Global Dolutegravir Price by Application (2027-2032) & (US$/pcs) Table 61. North America Dolutegravir Sales by Application (2021-2026) & (k pcs) Table 62. North America Dolutegravir Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Dolutegravir Sales by Application (2021-2026) & (k pcs) Table 64. Europe Dolutegravir Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Dolutegravir Sales by Application (2021-2026) & (k pcs) Table 66. Asia-Pacific Dolutegravir Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Dolutegravir Sales by Application (2021-2026) & (k pcs) Table 68. Latin America Dolutegravir Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Dolutegravir Sales by Application (2021-2026) & (k pcs) Table 70. Middle East and Africa Dolutegravir Sales by Application (2021-2026) & (US$ Million) Table 71. Shanghai Desano Pharmaceuticals Company Information Table 72. Shanghai Desano Pharmaceuticals Business Overview Table 73. Shanghai Desano Pharmaceuticals Dolutegravir Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 74. Shanghai Desano Pharmaceuticals Dolutegravir Product Portfolio Table 75. Shanghai Desano Pharmaceuticals Recent Development Table 76. Mylan Company Information Table 77. Mylan Business Overview Table 78. Mylan Dolutegravir Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 79. Mylan Dolutegravir Product Portfolio Table 80. Mylan Recent Development Table 81. ViiV Healthcare (GSK) Company Information Table 82. ViiV Healthcare (GSK) Business Overview Table 83. ViiV Healthcare (GSK) Dolutegravir Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 84. ViiV Healthcare (GSK) Dolutegravir Product Portfolio Table 85. ViiV Healthcare (GSK) Recent Development Table 86. LAURUS Labs Company Information Table 87. LAURUS Labs Business Overview Table 88. LAURUS Labs Dolutegravir Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 89. LAURUS Labs Dolutegravir Product Portfolio Table 90. LAURUS Labs Recent Development Table 91. Aurobindo Pharma Company Information Table 92. Aurobindo Pharma Business Overview Table 93. Aurobindo Pharma Dolutegravir Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 94. Aurobindo Pharma Dolutegravir Product Portfolio Table 95. Aurobindo Pharma Recent Development Table 96. Adcock Ingram Limited Company Information Table 97. Adcock Ingram Limited Business Overview Table 98. Adcock Ingram Limited Dolutegravir Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 99. Adcock Ingram Limited Dolutegravir Product Portfolio Table 100. Adcock Ingram Limited Recent Development Table 101. North America Dolutegravir Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 102. North America Dolutegravir Sales by Country (2021-2026) & (k pcs) Table 103. North America Dolutegravir Sales Market Share by Country (2021-2026) Table 104. North America Dolutegravir Sales Forecast by Country (2027-2032) & (k pcs) Table 105. North America Dolutegravir Sales Market Share Forecast by Country (2027-2032) Table 106. North America Dolutegravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Dolutegravir Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Dolutegravir Market Share by Country (2021-2026) Table 109. North America Dolutegravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Dolutegravir Market Share Forecast by Country (2027-2032) Table 111. Europe Dolutegravir Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 112. Europe Dolutegravir Sales by Country (2021-2026) & (k pcs) Table 113. Europe Dolutegravir Sales Market Share by Country (2021-2026) Table 114. Europe Dolutegravir Sales Forecast by Country (2027-2032) & (k pcs) Table 115. Europe Dolutegravir Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Dolutegravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Dolutegravir Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Dolutegravir Market Share by Country (2021-2026) Table 119. Europe Dolutegravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Dolutegravir Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Dolutegravir Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Dolutegravir Sales by Country (2021-2026) & (k pcs) Table 123. Asia-Pacific Dolutegravir Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Dolutegravir Sales Forecast by Country (2027-2032) & (k pcs) Table 125. Asia-Pacific Dolutegravir Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Dolutegravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Dolutegravir Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Dolutegravir Market Share by Country (2021-2026) Table 129. Asia-Pacific Dolutegravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Dolutegravir Market Share Forecast by Country (2027-2032) Table 131. Latin America Dolutegravir Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 132. Latin America Dolutegravir Sales by Country (2021-2026) & (k pcs) Table 133. Latin America Dolutegravir Sales Market Share by Country (2021-2026) Table 134. Latin America Dolutegravir Sales Forecast by Country (2027-2032) & (k pcs) Table 135. Latin America Dolutegravir Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Dolutegravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Dolutegravir Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Dolutegravir Market Share by Country (2021-2026) Table 139. Latin America Dolutegravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Dolutegravir Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Dolutegravir Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Dolutegravir Sales by Country (2021-2026) & (k pcs) Table 143. Middle East and Africa Dolutegravir Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Dolutegravir Sales Forecast by Country (2027-2032) & (k pcs) Table 145. Middle East and Africa Dolutegravir Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Dolutegravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Dolutegravir Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Dolutegravir Market Share by Country (2021-2026) Table 149. Middle East and Africa Dolutegravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Dolutegravir Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Dolutegravir Distributors List Table 154. Dolutegravir Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Dolutegravir Image Figure 2. Global Dolutegravir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dolutegravir Market Size (2021-2032) & (US$ Million) Figure 4. Global Dolutegravir Sales (2021-2032) & (k pcs) Figure 5. 10mg Tablets Image Figure 6. Global 10mg Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 7. 50mg Tablets Image Figure 8. Global 50mg Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 9. Global Dolutegravir Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Dolutegravir Market Share by Type 2025 VS 2032 Figure 11. North America Dolutegravir Sales Market Share in Volume by Type in 2025 Figure 12. North America Dolutegravir Sales Market Share in Value by Type in 2025 Figure 13. Europe Dolutegravir Sales Market Share in Volume by Type in 2025 Figure 14. Europe Dolutegravir Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Dolutegravir Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Dolutegravir Sales Market Share in Value by Type in 2025 Figure 17. Latin America Dolutegravir Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Dolutegravir Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Dolutegravir Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Dolutegravir Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Dolutegravir Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Prevent HIV Infection Following Potential Exposure Image Figure 24. Global Prevent HIV Infection Following Potential Exposure Sales YoY Growth (2021-2032) & (k pcs) Figure 25. Others Image Figure 26. Global Others Sales YoY Growth (2021-2032) & (k pcs) Figure 27. Global Dolutegravir Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Dolutegravir Market Share by Application 2025 VS 2032 Figure 29. North America Dolutegravir Sales Market Share in Volume by Application in 2025 Figure 30. North America Dolutegravir Sales Market Share in Value by Application in 2025 Figure 31. Europe Dolutegravir Sales Market Share in Volume by Application in 2025 Figure 32. Europe Dolutegravir Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Dolutegravir Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Dolutegravir Sales Market Share in Value by Application in 2025 Figure 35. Latin America Dolutegravir Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Dolutegravir Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Dolutegravir Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Dolutegravir Sales Market Share in Value by Application in 2025 Figure 39. North America Dolutegravir Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 40. North America Dolutegravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Dolutegravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Dolutegravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Dolutegravir Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 44. Europe Dolutegravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Dolutegravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Dolutegravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Dolutegravir Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 48. Asia-Pacific Dolutegravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Dolutegravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Dolutegravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Dolutegravir Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 52. Latin America Dolutegravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Dolutegravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Dolutegravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Dolutegravir Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 56. Middle East and Africa Dolutegravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Dolutegravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Dolutegravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Dolutegravir Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Dolutegravir Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg Tablets
  • 50mg Tablets
Applications
  • Prevent HIV Infection Following Potential Exposure
  • Others
Companies covered
  • Shanghai Desano Pharmaceuticals
  • Mylan
  • ViiV Healthcare (GSK)
  • LAURUS Labs
  • Aurobindo Pharma
  • Adcock Ingram Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dolutegravir Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dolutegravir Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dolutegravir Market by Type
  6. 1.3.1 10mg Tablets
  7. 1.3.2 50mg Tablets
  8. 1.4 Global Dolutegravir Market Size by Type
  9. 1.4.1 Global Dolutegravir Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Dolutegravir Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Dolutegravir Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Dolutegravir Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Dolutegravir Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Dolutegravir Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Dolutegravir Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Dolutegravir Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dolutegravir Industry Trends
  2. 2.2 Dolutegravir Industry Drivers
  3. 2.3 Dolutegravir Industry Opportunities and Challenges
  4. 2.4 Dolutegravir Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dolutegravir Revenue (2021-2026)
  2. 3.2 Global Top Players by Dolutegravir Sales (2021-2026)
  3. 3.3 Global Top Players by Dolutegravir Price (2021-2026)
  4. 3.4 Global Dolutegravir Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dolutegravir Major Company Production Sites & Headquarters
  6. 3.6 Global Dolutegravir Company, Product Type & Application
  7. 3.7 Global Dolutegravir Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dolutegravir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dolutegravir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dolutegravir Tier 1, Tier 2, and Tier 3
4 Dolutegravir Regional Status and Outlook
  1. 4.1 Global Dolutegravir Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dolutegravir Historic Market Size by Region
  3. 4.2.1 Global Dolutegravir Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dolutegravir Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dolutegravir Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dolutegravir Forecasted Market Size by Region
  7. 4.3.1 Global Dolutegravir Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dolutegravir Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dolutegravir Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dolutegravir by Application
  1. 5.1 Dolutegravir Market by Application
  2. 5.1.1 Prevent HIV Infection Following Potential Exposure
  3. 5.1.2 Others
  4. 5.2 Global Dolutegravir Market Size by Application
  5. 5.2.1 Global Dolutegravir Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Dolutegravir Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Dolutegravir Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Dolutegravir Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Dolutegravir Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Dolutegravir Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Dolutegravir Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Dolutegravir Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai Desano Pharmaceuticals
  2. 6.1.1 Shanghai Desano Pharmaceuticals Company Information
  3. 6.1.2 Shanghai Desano Pharmaceuticals Business Overview
  4. 6.1.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai Desano Pharmaceuticals Dolutegravir Product Portfolio
  6. 6.1.5 Shanghai Desano Pharmaceuticals Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Dolutegravir Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Dolutegravir Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 ViiV Healthcare (GSK)
  14. 6.3.1 ViiV Healthcare (GSK) Company Information
  15. 6.3.2 ViiV Healthcare (GSK) Business Overview
  16. 6.3.3 ViiV Healthcare (GSK) Dolutegravir Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 ViiV Healthcare (GSK) Dolutegravir Product Portfolio
  18. 6.3.5 ViiV Healthcare (GSK) Recent Developments
  19. 6.4 LAURUS Labs
  20. 6.4.1 LAURUS Labs Company Information
  21. 6.4.2 LAURUS Labs Business Overview
  22. 6.4.3 LAURUS Labs Dolutegravir Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 LAURUS Labs Dolutegravir Product Portfolio
  24. 6.4.5 LAURUS Labs Recent Developments
  25. 6.5 Aurobindo Pharma
  26. 6.5.1 Aurobindo Pharma Company Information
  27. 6.5.2 Aurobindo Pharma Business Overview
  28. 6.5.3 Aurobindo Pharma Dolutegravir Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Aurobindo Pharma Dolutegravir Product Portfolio
  30. 6.5.5 Aurobindo Pharma Recent Developments
  31. 6.6 Adcock Ingram Limited
  32. 6.6.1 Adcock Ingram Limited Company Information
  33. 6.6.2 Adcock Ingram Limited Business Overview
  34. 6.6.3 Adcock Ingram Limited Dolutegravir Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Adcock Ingram Limited Dolutegravir Product Portfolio
  36. 6.6.5 Adcock Ingram Limited Recent Developments
7 North America by Country
  1. 7.1 North America Dolutegravir Sales by Country
  2. 7.1.1 North America Dolutegravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dolutegravir Sales by Country (2021-2026)
  4. 7.1.3 North America Dolutegravir Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dolutegravir Market Size by Country
  6. 7.2.1 North America Dolutegravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dolutegravir Market Size by Country (2021-2026)
  8. 7.2.3 North America Dolutegravir Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dolutegravir Sales by Country
  2. 8.1.1 Europe Dolutegravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dolutegravir Sales by Country (2021-2026)
  4. 8.1.3 Europe Dolutegravir Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dolutegravir Market Size by Country
  6. 8.2.1 Europe Dolutegravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dolutegravir Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dolutegravir Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dolutegravir Sales by Country
  2. 9.1.1 Asia-Pacific Dolutegravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dolutegravir Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dolutegravir Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dolutegravir Market Size by Country
  6. 9.2.1 Asia-Pacific Dolutegravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dolutegravir Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dolutegravir Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dolutegravir Sales by Country
  2. 10.1.1 South America Dolutegravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dolutegravir Sales by Country (2021-2026)
  4. 10.1.3 South America Dolutegravir Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dolutegravir Market Size by Country
  6. 10.2.1 South America Dolutegravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dolutegravir Market Size by Country (2021-2026)
  8. 10.2.3 South America Dolutegravir Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dolutegravir Sales by Country
  2. 11.1.1 Middle East and Africa Dolutegravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dolutegravir Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dolutegravir Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dolutegravir Market Size by Country
  6. 11.2.1 Middle East and Africa Dolutegravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dolutegravir Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dolutegravir Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dolutegravir Value Chain Analysis
  2. 12.1.1 Dolutegravir Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dolutegravir Production Mode & Process
  7. 12.2 Dolutegravir Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dolutegravir Distributors
  10. 12.2.3 Dolutegravir Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst